Carotid Artery Disease
49
3
4
30
Key Insights
Highlights
Success Rate
81% trial completion
Published Results
16 trials with published results (33%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
14.3%
7 terminated out of 49 trials
81.1%
-5.4% vs benchmark
18%
9 trials in Phase 3/4
53%
16 of 30 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 30 completed trials
Clinical Trials (49)
High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC)
Perioperative Argon Inhalation to Improve Neurocognitive Recovery After Carotid Surgery
Neuropsychometric Outcome After Carotid Endarterectomy
NOR-SYS: The Norwegian Stroke in the Young Study
3D Multi-Contrast Atherosclerosis Characterization of the Carotid Artery
The Acute Effect of Statins on Inflammatory Markers of Athersclerotic Tissue
Salts of Clopidogrel: Investigation to ENsure Clinical Equivalence
Effects of VitamIN K2 and D3 supplementaTion on PET/MRI in Carotid Artery Disease
Telerobotic Ultrasound for Carotid Imaging - Feasibility Study
SVS VQI TransCarotid Revascularization Surveillance Project
Evaluation of a Novel Technique to Investigate CAS Piezo Electric Sensors
CARotid plaqUe StabilizatiOn and Regression With Evolocumab.
Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial
Feasibility Study of Simvastatin in Hodgkin's Lymphoma Survivors
Norwegian Carotid Plaque Study
A Single Center of Carotid Stenting With Distal Protection for the Treatment of Obstructive Carotid Artery Disease
The Gore SCAFFOLD Clinical Study
Carotid With Bivalirudin Angioplasty
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
POST-APPROVAL STUDY of TRANSCAROTID ARTERY REVASCULARIZATION in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE